Article Text

FRI0050 CYR61 induces IL-6 production by fibroblast-like synoviocytes promoting TH17 differentiation in rheumatoid arthritis
  1. N.L. Li1,
  2. J. Lin1,
  3. Z. Zhou2,
  4. R. Huo1,
  5. L. Xiao3,
  6. G. Ouyang3,
  7. N. Li2
  1. 1Shanghai Institute of Immunology, Shanghai Jiaotong University
  2. 2Shanghai Institute of Immunology
  3. 3Guanghua Rheumatology Hospital, Shanghai, China


Background Cyr61/CCN1 is a product of an immediate early gene which functions in mediating cell adhesion and inducing cell migration. We previously showed that increased production of Cyr61 by fibroblast-like synoviocytes (FLS) in RA promotes FLS proliferation and participates in RA pathogenesis with IL-17 dependent pathway. However, whether Cyr61 in turn regulates Th17 cell differentiation and further enhances inflammation of RA remained unknown.

Objectives To explored the potential role of Cyr61 as a pro-inflammatory factor to promote Th17 differentiation in RA pathogenesis.

Methods Th17 differentiation was studied in a co-culture system of CD4+ T and FLS cells. Collagen-induced arthritis (CIA) mice were used as the RA animal model to test the therapeutic effect of anti-Cyr61 antibody as well as its effect on IL-6 production by FLS and Th17 differentiation in vivo. Expression of cytokines was measured by ELISA, real-time PCR and flow cytometry, other factors by real-time PCR, western blotting or confocal microscopy.

Results Cyr61 stimulated IL-6 production by FLS, via the Cyr61/αvβ5/Akt/NF-kB signaling pathway. Increased IL-6 in turn promoted Th17 differentiation. Blocking Cyr61 action with a monoclonal antibody (093G9) reduced IL-6 production by FLS, attenuated Th17 response, and ameliorated disease progression in CIA mice.

Conclusions Cyr61 plays a critical role in stimulating IL-6 expression by FLS in RA and contributes to Th17 cell differentiation, and thus is likely a key molecule involved in the inflammation process of RA. Targeting Cyr61 may be a novel therapeutic strategy for RA.

  1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423(6937):356-61.

  2. Gaffen SL. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep 2009;11(5):365-70.

  3. Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, et al. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 2009;60(12):3602-12.

  4. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009;41(4):771-83.

  5. Jun JI, Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discovery 2011;10, doi: 10.1038/nrd3599

  6. Zhou, L., Ivanov, II, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-974.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.